Glen Eagle Advisors’s Colgate-Palmolive CL Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q1 | $45.1K | Hold |
529
| – | – | 0.01% | 461 |
|
|
2025
Q4 | $41.8K | Sell |
529
-453
| -46% | -$35.5K | 0.01% | 477 |
|
|
2025
Q3 | $78.5K | Sell |
982
-5
| -0.5% | -$427 | 0.01% | 367 |
|
|
2025
Q2 | $89.7K | Sell |
987
-50
| -5% | -$4.57K | 0.01% | 328 |
|
|
2025
Q1 | $97.1K | Sell |
1,037
-116
| -10% | -$10.4K | 0.02% | 313 |
|
|
2024
Q4 | $105K | Buy |
1,153
+1
| +0.1% | +$95 | 0.02% | 300 |
|
|
2024
Q3 | $120K | Buy |
1,152
+200
| +21% | +$20.4K | 0.02% | 295 |
|
|
2024
Q2 | $92.4K | Buy |
952
+111
| +13% | +$10.2K | 0.02% | 313 |
|
|
2024
Q1 | $75.7K | Sell |
841
-116
| -12% | -$9.83K | 0.01% | 344 |
|
|
2023
Q4 | $76.3K | Sell |
957
-50
| -5% | -$3.76K | 0.02% | 332 |
|
|
2023
Q3 | $71.6K | Hold |
1,007
| – | – | 0.02% | 329 |
|
|
2023
Q2 | $77.6K | Hold |
1,007
| – | – | 0.02% | 325 |
|
|
2023
Q1 | $75.7K | Sell |
1,007
-108
| -10% | -$8.03K | 0.02% | 315 |
|
|
2022
Q4 | $87.9K | Hold |
1,115
| – | – | 0.02% | 288 |
|
|
2022
Q3 | $78.3K | Hold |
1,115
| – | – | 0.02% | 295 |
|
|
2022
Q2 | $89.4K | Buy |
1,115
+1
| +0.1% | +$78 | 0.02% | 290 |
|
|
2022
Q1 | $84.5K | Hold |
1,114
| – | – | 0.02% | 302 |
|
|
2021
Q4 | $95K | Buy |
1,114
+1
| +0.1% | +$78 | 0.02% | 284 |
|
|
2021
Q3 | $84.1K | Buy |
1,113
+1
| +0.1% | +$79 | 0.02% | 296 |
|
|
2021
Q2 | $90.5K | Hold |
1,112
| – | – | 0.03% | 280 |
|
|
2021
Q1 | $87.6K | Buy |
1,112
+1
| +0.1% | +$78 | 0.03% | 267 |
|
|
2020
Q4 | $95K | Sell |
1,111
-8
| -0.7% | -$662 | 0.04% | 240 |
|
|
2020
Q3 | $86.3K | Buy |
1,119
+1
| +0.1% | +$76 | 0.04% | 235 |
|
|
2020
Q2 | $81.9K | Buy |
1,118
+502
| +81% | +$35.7K | 0.04% | 229 |
|
|
2020
Q1 | $40.9K | Hold |
616
| – | – | 0.03% | 287 |
|
|
2019
Q4 | $42.4K | Buy |
616
+500
| +431% | +$34.1K | 0.02% | 340 |
|
|
2019
Q3 | $8.53K | Buy |
116
+71
| +158% | +$5.15K | 0.01% | 536 |
|
|
2019
Q2 | $3.23K | Buy |
45
+11
| +32% | +$781 | ﹤0.01% | 665 |
|
|
2019
Q1 | $2.33K | Buy |
34
+13
| +62% | +$840 | ﹤0.01% | 641 |
|
|
2018
Q4 | $1.25K | Buy |
+21
| New | +$1.31K | ﹤0.01% | 660 |
|
|
2018
Q1 | – | Sell |
-23
| Closed | -$1.74K | – | 686 |
|
|
2017
Q4 | $1.74K | Sell |
23
-1
| -4% | -$73 | ﹤0.01% | 579 |
|
|
2017
Q3 | $1.75K | Hold |
24
| – | – | ﹤0.01% | 589 |
|
|
2017
Q2 | $1.78K | Buy |
+24
| New | +$1.78K | ﹤0.01% | 542 |
|
|
2017
Q1 | – | Sell |
-15
| Closed | -$982 | – | 549 |
|
|
2016
Q4 | $982 | Buy |
+15
| New | +$1.03K | ﹤0.01% | 518 |
|
Other funds holding CL
VCM
DAM
VPM
Glen Eagle Advisors's CL Position: Q1 2026 in Review
Glen Eagle Advisors held its Colgate-Palmolive (CL) position steady in Q1 2026 at 529 shares worth $45.1K. The position accounts for 0.01% of the portfolio, ranked #461.
Glen Eagle Advisors first reported a position in CL in Q4 2016 and has held it in 34 quarters since. The position peaked at $120K in Q3 2024. 1,947 funds tracked by Wall St. Rank hold CL as of Q1 2026.
- Glen Eagle Advisors held 529 shares of Colgate-Palmolive worth $45.1K as of Q1 2026.
- Glen Eagle Advisors left its Colgate-Palmolive share count unchanged in Q1 2026.
- Colgate-Palmolive made up 0.01% of Glen Eagle Advisors's portfolio in Q1 2026, its #461 holding.
- Glen Eagle Advisors first reported a position in Colgate-Palmolive in Q4 2016 and has held it in 34 quarters since.
- Glen Eagle Advisors's Colgate-Palmolive position peaked at $120K in Q3 2024.
- 1,947 funds tracked by Wall St. Rank held Colgate-Palmolive as of Q1 2026.
Based on Glen Eagle Advisors's 13F filing for Q1 2026, filed 15 May 2026.